Similar articles

• Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.

  Celani MF, Bonati ME, Stucci N. Celani MF, et al. Diabetes Res. 1994;27(1):15-25. Diabetes Res. 1994. PMID: 7648793
• Diseases of the thyroid gland.

  Evered D. Evered D. Clin Endocrinol Metab. 1974 Nov;3(3):425-50. doi: 10.1016/s0300-595x(74)80035-6. Clin Endocrinol Metab. 1974. PMID: 4141656 Review. No abstract available.
• The dilemma of abnormal thyroid function tests--is thyroid disease present or not?

  Griffin JE. Griffin JE. Am J Med Sci. 1985 Feb;289(2):76-88. doi: 10.1097/00000441-198502000-00008. Am J Med Sci. 1985. PMID: 3883772 Review. No abstract available.
• [Subclinical thyroid disease].

  Stöckli R. Stöckli R. Praxis (Bern 1994). 2007 Dec 19;96(51-52):2047-50. doi: 10.1024/1661-8157.96.51.2047. Praxis (Bern 1994). 2007. PMID: 18217651 Review. German.
• Evaluated reference intervals for serum free thyroxine and thyrotropin using the conventional outliner rejection test without regard to presence of thyroid antibodies and prevalence of thyroid dysfunction in Japanese subjects.

  Takeda K, Mishiba M, Sugiura H, Nakajima A, Kohama M, Hiramatsu S. Takeda K, et al. Endocr J. 2009;56(9):1059-66. doi: 10.1507/endocrj.k09e-123. Epub 2009 Sep 9. Endocr J. 2009. PMID: 19738362